subject area of

• Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide  Academic Article
• Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial  Academic Article
• Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial  Academic Article
• Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial  Academic Article
• The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial  Academic Article